These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 8279537

  • 1. Effects of recombinant human IGF-I on glucose and leucine kinetics in men.
    Elahi D, McAloon-Dyke M, Fukagawa NK, Sclater AL, Wong GA, Shannon RP, Minaker KL, Miles JM, Rubenstein AH, Vandepol CJ.
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E831-8. PubMed ID: 8279537
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R, Ninnis R, Keller U.
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of human recombinant insulin-like growth factor I and insulin on plasma amino acid concentrations and leucine kinetics in humans.
    Giordano M, Castellino P, Carroll CA, DeFronzo RA.
    Diabetologia; 1995 Jun; 38(6):732-8. PubMed ID: 7672498
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
    Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB, Umpleby AM.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
    [Abstract] [Full Text] [Related]

  • 5. Five weeks of insulin-like growth factor-I treatment does not alter glucose kinetics or insulin sensitivity during a hyperglycemic clamp in older women.
    Braun B, Friedlander AL, Pollack M, Butterfield GE, Marcus R, Hoffman AR.
    Metabolism; 2003 Sep; 52(9):1182-90. PubMed ID: 14506625
    [Abstract] [Full Text] [Related]

  • 6. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
    Kerr D, Tamborlane WV, Rife F, Sherwin RS.
    J Clin Invest; 1993 Jan; 91(1):141-7. PubMed ID: 8423214
    [Abstract] [Full Text] [Related]

  • 7. Short-term hypocaloric nutrition but not bed rest decrease insulin sensitivity and IGF-I bioavailability in healthy subjects: the importance of glucagon.
    Nygren J, Thorell A, Brismar K, Karpe F, Ljungqvist O.
    Nutrition; 1997 Jan; 13(11-12):945-51. PubMed ID: 9433709
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.
    Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS.
    J Clin Invest; 1994 Mar; 93(3):1131-9. PubMed ID: 8132753
    [Abstract] [Full Text] [Related]

  • 9. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the effects of insulin-like growth factor-I, insulin and combined infusions of insulin and insulin-like growth factor-I on glucose metabolism in dogs.
    Shojaee-Moradie F, Umpleby AM, Thomason MJ, Jackson NC, Boroujerdi MA, Sönksen PH, Skottner A, Jones RH.
    Eur J Clin Invest; 1995 Dec; 25(12):920-8. PubMed ID: 8719932
    [Abstract] [Full Text] [Related]

  • 11. Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Laager R, Keller U.
    Diabetologia; 1993 Oct; 36(10):966-71. PubMed ID: 8243878
    [Abstract] [Full Text] [Related]

  • 12. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL, Harris DA, Matyka KA, Watts AP, Umpleby AM, Russell-Jones DL, Dunger DB.
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [Abstract] [Full Text] [Related]

  • 13. Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man.
    Turkalj I, Keller U, Ninnis R, Vosmeer S, Stauffacher W.
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1186-91. PubMed ID: 1430077
    [Abstract] [Full Text] [Related]

  • 14. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
    Lucidi P, Lauteri M, Laureti S, Celleno R, Santoni S, Volpi E, Angeletti G, Santeusanio F, De Feo P.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.
    Jacob R, Barrett E, Plewe G, Fagin KD, Sherwin RS.
    J Clin Invest; 1989 May; 83(5):1717-23. PubMed ID: 2651479
    [Abstract] [Full Text] [Related]

  • 16. Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans.
    Oehri M, Ninnis R, Girard J, Frey FJ, Keller U.
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E552-8. PubMed ID: 8928758
    [Abstract] [Full Text] [Related]

  • 17. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T, Shojaee-Moradie F, Williams RM, Amin R, Yuen KC, Watts A, Acerini CL, Umpleby AM, Dunger DB.
    Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
    [Abstract] [Full Text] [Related]

  • 18. Effects of insulin-like growth factor-I (IGF-I), insulin and combined IGF-I-insulin infusions on protein metabolism in dogs.
    Umpleby AM, Shojaee-Moradie F, Thomason MJ, Kelly JM, Skottner A, Sonksen PH, Jones RH.
    Eur J Clin Invest; 1994 May; 24(5):337-44. PubMed ID: 8088310
    [Abstract] [Full Text] [Related]

  • 19. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
    Mauras N, Horber FF, Haymond MW.
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
    [Abstract] [Full Text] [Related]

  • 20. Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments.
    Nauck MA, Stöckmann F, Thiery J, Ebert R, Creutzfeldt W.
    Horm Metab Res Suppl; 1988 Nov; 18():60-7. PubMed ID: 3056814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.